Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology), MACG (USA), UEG GI ASSOCIATE (VIENNA), MMED Gastroenterology Fellow (UK)
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology), MACG (USA), UEG GI ASSOCIATE (VIENNA), MMED Gastroenterology Fellow (UK)
Diabetologist
MBBS, Diploma in Diabetes from BIDE
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., Diplomat American Board of Internal Medicine
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
MBBS, MRCP (Medicine), FRCP (Glasgow)
Endocrinologist
MBBS, FCPS (Medicine), FCPS (Endocrinology)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), Certified Diabetologist (UK)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), Certified Diabetologist (UK)
Family Physician
MBBS, MCPS (Family Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures